ARMP Earnings Armata Pharmaceuticals, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | -1.12 | 2026-08-12 | 10-Q |
| Q1 2026 | 2026-03-31 | -3.16 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -4.80 | 2026-03-25 | 10-K |
| Q3 2025 | 2025-09-30 | -1.37 | 2025-11-12 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.63 | 2026-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.20 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -0.89 | 2026-03-25 | 10-K |
| Q3 2025 | 2024-09-30 | -0.60 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.45 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.69 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -1.91 | 2025-03-21 | 10-K |
| Q3 2024 | 2023-09-30 | -1.36 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.50 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.40 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -1.08 | 2024-03-21 | 10-K |
| Q3 2023 | 2022-09-30 | -0.79 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.55 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.30 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -0.96 | 2023-03-16 | 10-K |
| Q3 2022 | 2021-09-30 | -0.73 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.52 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.27 | 2022-05-12 | 10-Q |
| FY 2021 | 2020-12-31 | -1.35 | 2022-03-17 | 10-K |
| Q3 2020 | 2020-09-30 | -0.99 | 2020-11-12 | 10-Q |
| Q2 2020 | 2020-06-30 | -0.68 | 2020-08-13 | 10-Q |
| FY 2020 | 2019-12-31 | -2.55 | 2021-03-18 | 10-K |
| Q3 2020 | 2019-09-30 | -2.11 | 2020-11-12 | 10-Q |
| Q2 2020 | 2019-06-30 | -1.38 | 2020-08-13 | 10-Q |
| Q1 2019 | 2019-03-31 | -0.11 | 2019-05-06 | 10-Q |
| FY 2019 | 2018-12-31 | -3.59 | 2020-03-19 | 10-K |
| Q3 2019 | 2018-09-30 | -3.35 | 2019-11-12 | 10-Q |
| Q2 2019 | 2018-06-30 | -2.76 | 2019-08-14 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.24 | 2019-05-06 | 10-Q |
| FY 2018 | 2017-12-31 | -2.18 | 2019-03-25 | 10-K |
| Q3 2018 | 2017-09-30 | -2.18 | 2018-11-08 | 10-Q |
| Q2 2018 | 2017-06-30 | -3.09 | 2018-08-09 | 10-Q |
| FY 2017 | 2016-12-31 | -24.67 | 2018-03-14 | 10-K |
| Q3 2017 | 2016-09-30 | -17.72 | 2017-11-14 | 10-Q |
| Q2 2017 | 2016-06-30 | -15.96 | 2017-08-14 | 10-Q |
| FY 2016 | 2016-03-31 | -0.82 | 2017-03-27 | 10-K |
| FY 2016 | 2015-12-31 | -0.54 | 2017-03-27 | 10-K |
| FY 2016 | 2015-09-30 | -0.30 | 2017-03-27 | 10-K |
| FY 2016 | 2015-06-30 | -0.33 | 2017-03-27 | 10-K |
| FY 2016 | 2015-03-31 | -3.49 | 2017-03-27 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.